Cargando…
Generation of Transplantable Beta Cells for Patient-Specific Cell Therapy
Islet cell transplantation offers a potential cure for type 1 diabetes, but it is challenged by insufficient donor tissue and side effects of current immunosuppressive drugs. Therefore, alternative sources of insulin-producing cells and isletfriendly immunosuppression are required to increase the ef...
Autores principales: | Wang, Xiaojie, Metzger, Daniel L., Meloche, Mark, Hao, Jianqiang, Ao, Ziliang, Warnock, Garth L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350967/ https://www.ncbi.nlm.nih.gov/pubmed/22611393 http://dx.doi.org/10.1155/2012/414812 |
Ejemplares similares
-
B7-H4 Pathway in Islet Transplantation and β-Cell Replacement Therapies
por: Wang, Xiaojie, et al.
Publicado: (2011) -
B7-H4 Treatment of T Cells Inhibits ERK, JNK, p38, and AKT Activation
por: Wang, Xiaojie, et al.
Publicado: (2012) -
Improving Islet Engraftment by Gene Therapy
por: Wang, Xiaojie, et al.
Publicado: (2011) -
Early Treatment of NOD Mice With B7-H4 Reduces the Incidence of Autoimmune Diabetes
por: Wang, Xiaojie, et al.
Publicado: (2011) -
Production of Functional Glucagon-Secreting α-Cells From Human Embryonic Stem Cells
por: Rezania, Alireza, et al.
Publicado: (2011)